Published in Thrombosis on September 16, 2012
Incidence of venous thromboembolism and hemorrhage related safety studies of preoperative anticoagulation therapy in hip fracture patients undergoing surgical treatment: a case-control study. BMC Musculoskelet Disord (2016) 0.83
New insights into the mechanisms of action of aspirin and its use in the prevention and treatment of arterial and venous thromboembolism. Ther Clin Risk Manag (2015) 0.77
Evidence-base for aspirin as venous thromboembolic prophylaxis following joint replacement. Bone Joint Res (2014) 0.76
The influence of VKORC1 and CYP2C9 mutations on warfarin response after total hip and knee arthroplasty. J Orthop (2015) 0.75
Venous Thromboembolism Prophylaxis After TKA: Aspirin, Warfarin, Enoxaparin, or Factor Xa Inhibitors? Clin Orthop Relat Res (2017) 0.75
Can patients with femoral neck fracture benefit from preoperative thromboprophylaxis?: A prospective randomized controlled trial. Medicine (Baltimore) (2017) 0.75
Prevention of venous thromboembolism: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition). Chest (2008) 16.17
Heparin-induced thrombocytopenia in patients treated with low-molecular-weight heparin or unfractionated heparin. N Engl J Med (1995) 6.86
Risk factors for venous thromboembolism. Circulation (2003) 4.64
Fondaparinux vs enoxaparin for the prevention of venous thromboembolism in major orthopedic surgery: a meta-analysis of 4 randomized double-blind studies. Arch Intern Med (2002) 3.96
Fondaparinux compared with enoxaparin for the prevention of venous thromboembolism after elective major knee surgery. N Engl J Med (2001) 2.54
Oral rivaroxaban for the prevention of symptomatic venous thromboembolism after elective hip and knee replacement. J Bone Joint Surg Br (2009) 1.91
Prevention of venous thromboembolic disease following primary total knee arthroplasty. A randomized, multicenter, open-label, parallel-group comparison of enoxaparin and warfarin. J Bone Joint Surg Am (2001) 1.87
A meta-analysis of thromboembolic prophylaxis following elective total hip arthroplasty. J Bone Joint Surg Am (2000) 1.57
Preventing venous thromboembolic disease in patients undergoing elective hip and knee arthroplasty. J Am Acad Orthop Surg (2011) 1.39
Venous thromboembolic disease after total hip and knee arthroplasty. J Bone Joint Surg Am (2008) 1.30
Prevention of deep-vein thrombosis after total hip arthroplasty. Comparison of warfarin and dalteparin. J Bone Joint Surg Am (1997) 1.16
Return to theatre following total hip and knee replacement, before and after the introduction of rivaroxaban: a retrospective cohort study. J Bone Joint Surg Br (2011) 1.15
Does aspirin have a role in venous thromboembolism prophylaxis in total knee arthroplasty patients? J Arthroplasty (2009) 1.07
Prevention of venous thromboembolic disease after total hip and knee arthroplasty. J Bone Joint Surg Am (2005) 1.04
Cost-effectiveness of rivaroxaban after total hip or total knee arthroplasty. Am J Manag Care (2011) 0.91
The benefit of aspirin chemoprophylaxis for thromboembolism after total knee arthroplasty. Clin Orthop Relat Res (2006) 0.90
Effect of aspirin on heterotopic ossification after total hip arthroplasty in men who have osteoarthrosis. J Bone Joint Surg Am (1991) 0.90
Low molecular weight heparin decreases proximal and distal deep venous thrombosis following total knee arthroplasty. A meta-analysis of randomized trials. Thromb Haemost (1998) 0.89
Pulmonary embolism prophylaxis in more than 30,000 total knee arthroplasty patients: is there a best choice? J Arthroplasty (2011) 0.86
The use of aspirin to prevent heterotopic ossification after total hip arthroplasty. A preliminary report. Clin Orthop Relat Res (1991) 0.84
A prospective comparison of warfarin to aspirin for thromboprophylaxis in total hip and total knee arthroplasty. J Arthroplasty (2011) 0.83
Warfarin prophylaxis in patients after total knee or hip arthroplasty--international normalized ratio patterns and venous thromboembolism. Curr Med Res Opin (2011) 0.82
New pentasaccharides for prophylaxis of deep vein thrombosis: pharmacology. Chest (2003) 0.82
Major bleeding rates after prophylaxis against venous thromboembolism: systematic review, meta-analysis, and cost implications. Int J Technol Assess Health Care (2004) 0.82
Efficacy and safety of fondaparinux in major orthopedic surgery according to the timing of its first administration. Thromb Haemost (2003) 0.80
DVT prophylaxis in total joint reconstruction. Orthop Clin North Am (2010) 0.79
The effect of posterior tibial slope on range of motion after total knee arthroplasty. J Arthroplasty (2006) 1.59
Computer assisted navigation in total knee arthroplasty: comparison with conventional methods. J Arthroplasty (2005) 1.45
A randomized prospective study evaluating the effect of patellar eversion on the early functional outcomes in primary total knee arthroplasty. J Arthroplasty (2007) 1.44
The use of a constrained acetabular component for recurrent dislocation. J Arthroplasty (2003) 1.40
Insertion of membrane proteins into discoidal membranes using a cell-free protein expression approach. J Proteome Res (2008) 1.34
Membrane protein expression: no cells required. Trends Biotechnol (2009) 1.25
Cell-free co-expression of functional membrane proteins and apolipoprotein, forming soluble nanolipoprotein particles. Mol Cell Proteomics (2008) 1.25
Evaluation of component positioning in primary total hip arthroplasty using an imageless navigation device compared with traditional methods. J Arthroplasty (2008) 1.13
Success of clinical pathways for total joint arthroplasty in a community hospital. Clin Orthop Relat Res (2007) 1.08
Computer-assisted navigation software advancements improve the accuracy of total knee arthroplasty. J Arthroplasty (2010) 1.05
Association between UHMWPE particle-induced inflammatory osteoclastogenesis and expression of RANKL, VEGF, and Flt-1 in vivo. Biomaterials (2006) 1.02
Design of orthogonal genetic switches based on a crosstalk map of σs, anti-σs, and promoters. Mol Syst Biol (2013) 1.02
Macrophage depletion diminishes implant-wear-induced inflammatory osteolysis in a mouse model. J Biomed Mater Res A (2008) 1.01
Expanding the spectral palette of fluorescent proteins for the green microalga Chlamydomonas reinhardtii. Plant J (2013) 0.95
High-sensitivity detection of DNA hybridization on microarrays using resonance light scattering. Anal Chem (2002) 0.88
Inflammatory and immunological responses to hyaluronan preparations. Study of a murine biocompatibility model. J Bone Joint Surg Am (2007) 0.88
Cell-free synthesis of a functional G protein-coupled receptor complexed with nanometer scale bilayer discs. BMC Biotechnol (2011) 0.87
Drain technique in elective total joint arthroplasty. Orthopedics (2014) 0.87
Efficacy of periprosthetic erythromycin delivery for wear debris-induced inflammation and osteolysis. Inflamm Res (2010) 0.87
Human periprosthetic tissues implanted in severe combined immunodeficient mice respond to gene transfer of a cytokine inhibitor. J Bone Joint Surg Am (2005) 0.85
Circulating blood monocytes traffic to and participate in the periprosthetic tissue inflammation. Inflamm Res (2009) 0.84
Dual mobility bearings withstand loading from steeper cup-inclinations without substantial wear. J Orthop Res (2014) 0.82
Lack of early dislocation following total hip arthroplasty with a new dual mobility acetabular design. Hip Int (2015) 0.82
Pull-out and shear failure strengths of arthroscopic meniscal repair systems. Knee Surg Sports Traumatol Arthrosc (2002) 0.81
Introgression of Brown Norway chromosome 13 improves visual spatial memory in the Dahl S rat. Behav Genet (2009) 0.81
Coaxial PCL/PVA electrospun nanofibers: osseointegration enhancer and controlled drug release device. Biofabrication (2013) 0.81
Does dual-mobility cup geometry affect posterior horizontal dislocation distance? Clin Orthop Relat Res (2014) 0.80
Cyclodextrin-erythromycin complexes as a drug delivery device for orthopedic application. Int J Nanomedicine (2011) 0.80
What factors affect posterior dislocation distance in THA? Clin Orthop Relat Res (2013) 0.79
The effects of acetabular shell deformation and liner thickness on frictional torque in ultrahigh-molecular-weight polyethylene acetabular bearings. J Arthroplasty (2009) 0.79
Impacts of age and gender on bone marrow profiles of BMP7, BMPRs and Stro-1⁺ cells in patients with total hip replacement. Int Orthop (2011) 0.79
Comparison of the effects of erythropoietin and anakinra on functional recovery and gene expression in a traumatic brain injury model. Front Pharmacol (2013) 0.79
Differentiation of septic and aseptic loosening by PET with both 11C-PK11195 and 18F-FDG in rat models. Nucl Med Commun (2012) 0.79
Blockade of vascular endothelial growth factor activity suppresses wear debris-induced inflammatory osteolysis. J Rheumatol (2007) 0.78
Infection in Orthopaedics. J Orthop Trauma (2015) 0.78
Constrained acetabular liners cemented into cages during total hip revision arthroplasty. J Arthroplasty (2010) 0.77
Evaluation of limb alignment, component positioning, and function in primary total knee arthroplasty using a pinless navigation technique compared with conventional methods. J Knee Surg (2012) 0.77
Poly(vinyl alcohol)/collagen/hydroxyapatite hydrogel: properties and in vitro cellular response. J Biomed Mater Res A (2012) 0.77
Effects of SU5416 and a vascular endothelial growth factor neutralizing antibody on wear debris-induced inflammatory osteolysis in a mouse model. J Inflamm Res (2011) 0.77
Effect of Traumatic Brain Injury, Erythropoietin, and Anakinra on Hepatic Metabolizing Enzymes and Transporters in an Experimental Rat Model. AAPS J (2015) 0.77
Advanced DNA assembly technologies in drug discovery. Expert Opin Drug Discov (2012) 0.77
Electrospun polyvinyl alcohol-collagen-hydroxyapatite nanofibers: a biomimetic extracellular matrix for osteoblastic cells. Nanotechnology (2012) 0.76
Shear force at failure and stiffness of all-inside meniscal repair devices. J Knee Surg (2013) 0.75
Emerging ideas: can erythromycin reduce the risk of aseptic loosening? Clin Orthop Relat Res (2011) 0.75
Improving Operating Room Efficiency, Part 2: Intraoperative and Postoperative Strategies. JBJS Rev (2015) 0.75
Effect of erythromycin-doped calcium polyphosphate scaffold composite in a mouse pouch infection model. J Biomed Mater Res B Appl Biomater (2013) 0.75
Simple techniques for passing suture through bone. Am J Orthop (Belle Mead NJ) (2005) 0.75
Bearing surfaces for hip arthroplasty - is metal-on-metal a passing fancy? Surg Technol Int (2012) 0.75
Novel angle measurements for assessment of shoulder location using the scapular y radiograph. Orthopedics (2011) 0.75
Elution Profiles of Two Methods of Antibiotic Tibial Nail Preparations. Orthopedics (2017) 0.75
Implant wear induced inflammation is mitigated in CX3CR1(-/-) mice. J Orthop Res (2014) 0.75
A novel strontium-doped calcium polyphosphate/erythromycin/poly(vinyl alcohol) composite for bone tissue engineering. J Biomed Mater Res A (2011) 0.75
Improving Operating Room Efficiency, Part 1: General Managerial and Preoperative Strategies. JBJS Rev (2015) 0.75